服用非索非那定患者曲马多尿假阳性:两个连续病例的故事。

Q4 Medicine

Case Reports in Psychiatry Pub Date : 2023-01-01 DOI:10.1155/2023/4370648

Suhair Mohammed Yousuf, Ahmad Maaen Alater, Majid Alabdulla, Mugtaba Osman

{"title":"服用非索非那定患者曲马多尿假阳性:两个连续病例的故事。","authors":"Suhair Mohammed Yousuf, Ahmad Maaen Alater, Majid Alabdulla, Mugtaba Osman","doi":"10.1155/2023/4370648","DOIUrl":null,"url":null,"abstract":"Urine drug screen immunoassays have been widely used as point-of-care testing for detection of various drug classes in substance use disorders. However, these immunoassays frequently result in false positive results. We report two patients that used 180 mg daily dose of fexofenadine hydrochloride for treatment of skin allergy and, falsely, tested positive for use of tramadol during urine drug screening. We recommend caution when interpreting positive tramadol urine screening among patients on fexofenadine treatment.","PeriodicalId":9631,"journal":{"name":"Case Reports in Psychiatry","volume":"2023 ","pages":"4370648"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836806/pdf/","citationCount":"0","resultStr":"{\"title\":\"False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases.\",\"authors\":\"Suhair Mohammed Yousuf, Ahmad Maaen Alater, Majid Alabdulla, Mugtaba Osman\",\"doi\":\"10.1155/2023/4370648\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Urine drug screen immunoassays have been widely used as point-of-care testing for detection of various drug classes in substance use disorders. However, these immunoassays frequently result in false positive results. We report two patients that used 180 mg daily dose of fexofenadine hydrochloride for treatment of skin allergy and, falsely, tested positive for use of tramadol during urine drug screening. We recommend caution when interpreting positive tramadol urine screening among patients on fexofenadine treatment.\",\"PeriodicalId\":9631,\"journal\":{\"name\":\"Case Reports in Psychiatry\",\"volume\":\"2023 \",\"pages\":\"4370648\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836806/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Case Reports in Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/4370648\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/4370648","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

尿液药物筛选免疫测定法已广泛应用于药物使用障碍中各种药物类别的检测。然而，这些免疫分析经常导致假阳性结果。我们报告了两例使用每日180mg剂量的盐酸非索非那定治疗皮肤过敏的患者，并在尿药物筛选中错误地检测出曲马多使用阳性。我们建议在解释接受非索非那定治疗的患者曲马多尿筛查阳性时要谨慎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases.

Urine drug screen immunoassays have been widely used as point-of-care testing for detection of various drug classes in substance use disorders. However, these immunoassays frequently result in false positive results. We report two patients that used 180 mg daily dose of fexofenadine hydrochloride for treatment of skin allergy and, falsely, tested positive for use of tramadol during urine drug screening. We recommend caution when interpreting positive tramadol urine screening among patients on fexofenadine treatment.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Case Reports in Psychiatry Medicine-Psychiatry and Mental Health

CiteScore

1.00

自引率

0.00%

发文量

审稿时长

12 weeks